Russia announces the development of an mRNA cancer vaccine, slated for a 2025 launch. Pre-clinical trials demonstrate tumor suppression and metastasis reduction. AI integration promises to personalize vaccine creation within an hour, significantly accelerating the current lengthy process. The vaccine aims to bolster the immune system’s ability to target and eliminate cancer cells.Russia has developed its own cancer vaccine
Russia announces the development of an mRNA cancer vaccine, slated for a 2025 launch. Pre-clinical trials demonstrate tumor suppression and metastasis reduction. AI integration promises to personalize vaccine creation within an hour, significantly accelerating the current lengthy process. The vaccine aims to bolster the immune system’s ability to target and eliminate cancer cells.